• We recommend therapy-naïve individuals start combination ART containing atazanavir/r, darunavir/r, dolutegravir, elvitegravir/c, raltegravir or rilpivirine as the third agent.
  • We suggest that for therapy-naïve individuals, efavirenz is an acceptable alternative third agent.